(Q48395213)

English

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

scientific article published on 26 August 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

phase II clinical trial

0 references

0 references

Heart failure with preserved ejection fraction

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

3

object named as

Burkert Pieske

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

Adriaan A Voors

4

object named as

Adriaan Voors

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

13

object named as

John J V McMurray

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

7

object named as

Victor Shi

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

2

object named as

Michael Zile

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

12

object named as

Milton Packer

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

Elisabeth Kraigher-Krainer

6

object named as

Elisabeth Kraigher-Krainer

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

5

object named as

Amil Shah

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

8

object named as

Toni Bransford

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

author name string

Scott D Solomon

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

Madoka Takeuchi

9

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

Jianjian Gong

10

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

Martin Lefkowitz

11

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators

14

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

language of work or name

0 references

publication date

26 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

380

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

9851

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

1387-1395

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology and clinical course of heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of heart failure with preserved ejection fraction in a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice. Diastolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased proximal arterial stiffness and cardiac response with moderate exercise in patients with heart failure and preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired Natriuretic and Renal Endocrine Response to Acute Volume Expansion in Pre-Clinical Systolic and Diastolic Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Irbesartan in patients with heart failure and preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Biology of the natriuretic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular biology of the natriuretic peptide system: implications for physiology and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Natriuretic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis in Heart Failure with a Normal Ejection Fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal Function and Neurohormonal Changes Following Intravenous Infusions of Nitroglycerin Versus Nesiritide in Patients With Acute Decompensated Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiac Resynchronization Therapy Reduces Left Atrial Volume and the Risk of Atrial Tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961227-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)61227-6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22932717

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48395213&oldid=2197025138"